Skip to main content
. 2023 Jan 3;108(7):1776–1786. doi: 10.1210/clinem/dgac752

Table 1.

Phenotypes of patients with WNT1 mutations at baseline

Patient No. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Sillence classification III III III III IV III IV IV IV III IV III EOOP EOOP EOOP EOOP
Sex F M F M M M M M M M M M F F M M
Family history No No No No No No No No No No No No Yes Yes No No
Consanguineous family No No Yes No No No No No No No No No No No Yes No
Age at first diagnosis, y 1.8 4.0 9.0 6.5 2.5 15.0 11.0 10.8 12.4 24.0 16.0 1.5 7.3 32.0 38.0 47.0
Age at first fracture, y 0 3 d 9 d 2 mo 10 mo 16 mo 2 3 8 10 13 0.5 3 6 27 47
Peripheral fracture, times 8 7 25 10 2 2 2 1 6 8 1 4 4 5 0a 0a
Multiple vertebral fractures Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes
Scoliosis No No Yes Yes No Yes No No No Yes No No No No Yes No
Limb deformities Yes Yes Yes Yes No No No No No Yes No Yes No No No No
Ptosis Yes No No Yes No No No No No No No Yes No No No No
Joint hypermobility No No Yes No No No No Yes No No No No No No No No
Blue sclera Yes Yes Yes No No Yes No Yes Yes No No No No No No No
Dentinogenesis imperfecta No No Yes No No No No No No No No No No No No No
Intellectual disability No No No No No No No No No No No No No No No Yes
Height, Z score −3.5 −2.2 −9.3 −1.6 0.1 −2.3 −1.7 −0.2 −0.8 −3.0 −0.3 −1.4 −0.5 1.2 −1.5 −1.1
Weight, Z score −0.7 −1.8 −7.1 −0.4 −1.0 −6.4 0.5 1.5 2.4 −0.9 0.3 0.6 0.7 −0.8 −1.4 1.3
LS BMD Z score −4.2 −7.9 −6.4 −0.5 −4.2 −6.4 −3.6 −4.2 −3.8 −4.4 −2.5 −8.5 −2.7 −3.0 −4.0 −2.6
FN BMD Z score −5.6 −1.9 −7.4 NA −5.2 −4.9 −4.1 −5.5 −5.3 −5.1 −3.1 −8.2 −4.9 −2.3 −3.7 −2.6
ALP, U/L 198 289 238 264 218 207 257 321 276 90 145 377 173 41 76 69
β-CTX, ng/mL 0.87 1.06 NA 1.11 1.05 0.70 1.06 1.30 0.50 0.20 NA 0.83 1.32 0.22 0.41 0.10

Patient 4, 5, and 16 had received antiresorptive treatment at baseline. FN BMD of the proximal femur in patient 4 was not unavailable because of the intramedullary nail.

Abbreviations: β-CTX, cross-linked C-telopeptide of type I collagen; ALP, alkaline phosphatase; BMD, bone mineral density; EEOP, early-onset osteoporosis; F, female; FN, femoral neck; LS, lumbar spine 2−4, M, male; NA, not available; TH, total hip.

Patients 15 and 16 had no peripheral fragility fractures and they went to the hospital because of back pain or low BMD identified at age 27 or 47 years.

HHS Vulnerability Disclosure